Lower Leg Remote Ischemic Preconditioning in Elective Percutaneous Coronary Intervention (PCI) (REMOTE)
Effects of Lower Leg Remote Ischemic Preconditioning in Combination With Electric Muscle Stimulation in Elective Coronary Artery Revascularisation
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
It has been demonstrated that protection from ischemia reperfusion can be achieved by brief periods of ischemia applied at a remote site during an injurious ischemic event (remote postconditioning). The purpose of this study is to investigate if the combination of brief periods of limb ischemia in combination with electric muscle stimulation at the same site could exceed the preconditioning effect of limb ischemia alone.
Therefore the investigators thought to perform 2 different forms of remote ischaemic preconditioning in patients undergoing elective coronary angioplasty.
In the first patient group a blood pressure cuff will be applied at the lower leg. Ischemia will be induced by inflating the cuff to a pressure of 200 mmHg for 5 minutes. Afterwards reperfusion will be allowed for further 5 minutes. This cycle will be repeated 3 times.
In a second patient group electric muscle stimulation at the same site (HiToP 191) will be performed additionally throughout the whole preconditioning cycle.
After preconditioning, the percutaneous coronary intervention (PCI) will be performed by 3 PCI-ballon inflations, each lasting for 2 minutes. Between the inflations coronary reperfusion will be allowed for 5 minutes.
The Effects of preconditioning will be evaluated by analysing the ST-deviation, caused by angioplasty in an intracoronary (derived by PCI wire) and surface ecg.
Also the maximum of chest pain during the 3 inflation cycles and troponin levels 24 h after PCI will be evaluated.
Tipo de estudio
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
MVP
-
Greifswald, MVP, Alemania, 17489
- Ernst Moritz Arndt Universität Greifswald
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- planned PCI of one of the main coronary artery (artery diameter distal of the stenotic area at least 2,5 mm)
- patient age 18 years or older
- stable angina pectoris symptoms
Exclusion Criteria:
- presence of collateral vessels
- electrocardiographic bundle branch blocks
- multiple coronary stenosis
- occlusion of a coronary artery
- renal insufficiency (GFR (MDRD) < 50 ml/min/1,73 m2)
- presence of coronary bypass grafts
- history or presence of myocardial infarction.
- echocardiographic signs of left ventricular hypertrophy (septal and/or posterior wall diameter greater than 14 mm)
- some sort of medications (adenosine, morphine and derivates, immunosuppressive agents, oral antibiotics, theophyllin, alpha receptor blockers)
- peripheral arterial disease
- exercise tests performed within 24 h before study start.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
control group
A Blood pressure cuff and and the muscle stimulator pads will be applied to one lower leg but without inflating the cuff and without stimulating the muscle.
Now 25 minutes will have to pass by before beginning the coronary angioplasty.
|
|
|
intervention group 1
A Blood pressure cuff and and the muscle stimulator pads will be applied to one lower leg.
The blood pressure Cuff will be inflated with 200 mmHg for 5 minutes.
Next reperfusion will be allowed for 5 minutes.
This cycle will be repeated for 3 times.
There will be no electrical muscle stimulation in this group.
|
A Blood pressure cuff and and the muscle stimulator pads will be applied to one lower leg.
The blood pressure cuff will be inflated with 200 mmHg for 5 minutes.
Next reperfusion will be allowed for 5 minutes.
This cycle will be repeated for 3 times.
|
|
intervention group 2
A Blood pressure cuff and the muscle stimulator pads will be applied to one lower leg.
The blood pressure Cuff will be inflated with 200 mmHg for 5 minutes.
Next reperfusion will be allowed for 5 minutes.
This cycle will be repeated for 3 times.
In addition electrical muscle stimulation will be performed throughout the whole preconditioning cycle
|
A Blood pressure cuff and and the muscle stimulator pads will be applied to one lower leg.
The blood pressure Cuff will be inflated with 200 mmHg for 5 minutes.
Next reperfusion will be allowed for 5 minutes.
This cycle will be repeated for 3 times.
In addition electrical muscle stimulation will be performed throughout the whole preconditioning cycle.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
ST deviation
Periodo de tiempo: 120 seconds after angioplasty
|
Immediately after the preconditioning cycle the PCI ballon will be positioned in the coronary artery lesion and inflated for 2 minutes followed by 5 minutes of reperfusion. This cycle will be repeated for 3 times without any interruption. Intracoronary ECGs and 12 lead surface ecgs will be taken immediately before and at the end of each ballon inflation (two minutes after beginning the intracoronary ballon inflation). after taking the ecgs the ballon will be deflated. The st-deviations will be analysed. |
120 seconds after angioplasty
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
troponin I
Periodo de tiempo: 24 hours after PCI
|
Troponin levels will be evaluated 24 h after PCI
|
24 hours after PCI
|
|
chest pain (Maximum)
Periodo de tiempo: time period 2 minutes
|
the maximal chest pain occuring during each of the Pci balloon inflations will be documented as a number out of 10. 0 is determined as no pain and 10 is determined as the heaviest pain which the patient ever experienced.
A specific timepoint has not been defined.
|
time period 2 minutes
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Markus Reinthaler, MD, Ernst Moritz Arndt University Greifswald
- Investigador principal: Thorsten Reffelmann, MD, Ernst Moritz Arndt University Greifswald
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 1-reinthaler
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .